GlassScriptPhysician profile
Apram Jyot
NPI 1972037448
$5,468.64
in general payments reported to CMS, 2019-2025
16 companies · $2,679 in 2025
The $2,679 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $817 · 2024: $1,972 · 2025: $2,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,468.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,720.22 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $720.32 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Mentor Worldwide LLC | $544.79 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $454.92 | 2023-2025 | |
| Avita Medical Americas, LLC | $449.97 | 2024-2025 | Permeaderm, Recell, Cohealyx |
| Axogen | $350.23 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Depuy Synthes Sales INC. | $318.77 | 2024-2025 | Trumatch, Na |
| Solventum Corporation | $170.89 | 2025 | Prevena |
| Acera Surgical, INC. | $165.64 | 2025 | Restrata Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $160.13 | 2023-2024 | |
| Polynovo North America LLC | $125.28 | 2024 | Novosorb Btm |
| Heron Therapeutics, INC. | $122.93 | 2025 | Zynrelef |
| Organogenesis INC. | $68.46 | 2024-2025 | Puraply Wound Matrix |
| Baxter Healthcare | $44.75 | 2025 | Artiss |
| Smith+Nephew, INC. | $37.77 | 2024 | Pico 7, Renasys Touch |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $13.57 | 2024 | Aesculap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apram Jyot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.